InvestorsHub Logo
Followers 154
Posts 2652
Boards Moderated 0
Alias Born 01/29/2004

Re: nidan7500 post# 168235

Thursday, 10/11/2018 1:10:49 PM

Thursday, October 11, 2018 1:10:49 PM

Post# of 463653
Ok. But, So What?


Any thoughts or comments on this PR from BIIB today.


https://finance.yahoo.com/news/biogen-advances-research-improve-outcomes-113000794.html

Not impressed; see no connection to Anavex (or much else). No big deal (compared to Anavex 2-73).

The company apparently is collaborating on some new multiple sclerosis diagnostic test. Wonderful. More accurately detect and diagnose the disease.

They are also accumulating data on efficacies on two of their drugs.

And they are “generating standardized data” (?) from 13,000 MS patients, checking cognitive changes.

Fine and dandy. But how does any of that actually help multiple sclerosis patients with new, useful, effective, and safe therapies? I don’t see anything of concern or interest. Don’t think the BIIB share price will ascend in regard to any of this. Don’t see that it has any connection to Anavex Life Sciences Corp or its shareholders.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News